Redesign of radiotherapy for prostate cancer: a proposal for universal healthcare systems

Author:

Beck da Silva Etges Ana Paula123ORCID,de Lara Luciana Rodrigues1,Sapper Stella Lisboa4,Frankenberg Berger Ana Von4,Streck Melissa4,Zardo Laise5,Linhares Armani67,Nassif Marina8,Zanotto Angélica1,Pereira Lima Marta Nassif8,Vargas Rafael165,Polanczyk Carisi Anne1389

Affiliation:

1. National Institute of Science & Technology for Health Technology Assessment (IATS) – CNPq/Brazil (project: 465518/2014-1), Porto Alegre, 90035-903, Brazil

2. Avant-garde Health, Boston, MA 02111, USA

3. Graduate Program in Epidemiology, Universidade Federal do Rio Grande do Sul School of Medicine, Porto Alegre, RS, 90035-002, Brazil

4. Crialab, Tecnopuc, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, 90619-900, Brazil

5. Hospital Santa Rita, Irmandade da Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, RS, 90020-090, Brazil

6. Department of Internal Medicine, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, RS, 90619-900, Brazil

7. Medicine course, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Porto Alegre, RS, 90050-170, Brazil

8. Universidade Federal do Rio Grande do Sul School of Medicine, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, 90619-900, Brazil

9. Hospital Moinhos de Vento, Porto Alegre, RS, 90035-000, Brazil

Abstract

Aim: This study was designed to recommend strategies to improve prostate patients' access to radiotherapy treatment in the Brazilian Unified Health System, along with a cost-tool to support radiotherapy care pathways' lead times and costs. Methods: Data was collected prospectively from patients with prostate cancer receiving radiotherapy in two Brazilian centers to provide data to apply design thinking and process reengineering techniques. The current status of the radiotherapy pathway was determined and the length of time taken for in-hospital activities was measured using data exported from ARIA ® . Interviews with patients were used to estimate their waiting periods. This provided the data used to provide recommended strategies and the cost tool based on time-driven activity-based costing. The strategies were classified according to priority. Results: Data from 47 patients were analyzed. The mean interval from diagnosis to start of radiotherapy was 349 days (SD581), and the mean interval from seeking medical attention to starting treatment was 635 days (SD629). Twelve strategies affecting in-hospital processes and 11 impacting patients' care pathways and experiences are recommended, mostly focused on system improvement opportunities. A time-driven activity-based costing monitoring using data extracted from ARIA was coded and can be used by centers as a cost assessment guide. Conclusion: This study uses reengineering and design techniques to introduce priority strategies to allow more efficient and patient-centered radiotherapy.

Publisher

Becaris Publishing Limited

Subject

Health Policy

Reference21 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J. Clin.,2018

2. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil. INCA, Brazil, p120 (2019).

3. DATASUS. Painel Oncologia. http://tabnet.datasus.gov.br/cgi/dhdat.exe?PAINEL_ONCO/PAINEL_ONCOLOGIABR.def (Accessed: 10 August 2022).

4. DATASUS. Mortalidade – desde 1996 pela CID-10. https://datasus.saude.gov.br/mortalidade-desde-1996-pela-cid-10 (Accessed: 10 August 2022).

5. Prostate cancer: ESMO consensus conference guidelines 2012;Horwich A;Ann. Oncol.,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3